A Study to Assess NEU-723 in Healthy Participants

NCT05633745 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Healthy

Interventions

DRUG: NEU-723
DRUG: Placebo

Sponsor

Neuron23 Inc.